-
3F Therapeutics, Inc.
Devices to treat heart valve disorders -
-
Achillion Pharmaceuticals, Inc.
Dedicated to bringing important new treatments to patients with infectious diseasehttp://www.achillion.com -
Acureon Pharmaceuticals, Inc.
Acquire and market drugs focused on infectious diseases, transplant and ICUhttp://www.acureonpharma.com -
-
Aesthetic Sciences Corporation
Aesthetic Sciences Corporation
Focused on aesthetic medicine and incontinence -
Afferent Pharmaceuticals, Inc.
Focused on developing first-in-class medicines to treat painhttp://www.afferentpharma.com -
Aldeyra Therapeutics, Inc.
Developing next-generation medicines to improve the lives of patients with immune-mediated diseaseshttp://www.aldeyra.com -
-
Alimera Sciences, Inc.
Development and marketing of in-licensed ophthalmology productshttp://www.alimerasciences.com -
Altair Therapeutics, Inc.
Developing novel therapeutics to treat human respiratory diseases -
Altea Therapeutics Corporation
Delivery of drugs across the skin -
Amgen Inc.
Focused on products for supportive cancer care, inflammation, nephrology and bone diseasehttp://www.amgen.com -
Amylin Pharmaceuticals, Inc.
Development of drugs to treat metabolic diseases -
Ansata Therapeutics, Inc.
Drug development utilizing cell targeting technology -
Antios Therapeutics, Inc.
Late-stage pre-clinical company focused on the treatment of the Hepatitis B Virushttp://antiostherapeutics.com -
Apnex Medical, Inc.
Developing a device-based treatment for obstructive sleep apnea -
Applied Biosystems
Technology solutions for DNA, RNA, protein, and small molecule analysishttp://www.appliedbiosystems.com -
Applied Molecular Evolution, Inc.
Applied Molecular Evolution, Inc.
Gene evolution technology to optimize proteins for drug and industrial use -
Applied Proteomics, Inc.
Developing protein biomarkers to improve healthcare and drug development -
Ariosa Diagnostics, Inc.
Focused on providing early, non-invasive, and accurate prenatal diagnostic tests for fetal healthhttp://www.ariosadx.com -
Ascenta Therapeutics, Inc.
Anti-cancer drug development -
-
Astute Medical, Inc.
Developing innovative, high value, biomarker solutions for the acute hospital settinghttp://www.astutemedical.com -
Atara Biotherapeutics, Inc.
Developing novel treatment options for patients with cancer and renal diseasehttp://www.atarabio.com/ -
Athena Neurosciences, Inc.
Athena Neurosciences, Inc.
Development of diagnostics and therapeutics for Alzheimer's Disease -
AtheroGenics, Inc.
Discovery and development of drugs for inflammatory diseases -
aTyr Pharma, Inc.
Developing Physiocrines, a novel class of naturally occuring biologics, for human therapeuticshttp://www.atyrpharma.com -
Aurora Biosciences Corporation
Aurora Biosciences Corporation
Automation to facilitate drug discovery processesAcquired by Vertex Pharmaceuticals -
Auxeris Therapeutics, Inc.
Osteoporosis drug development -
Axial Biotherapeutics, Inc.
Developing a new class of therapeutics to improve the quality of life for patients with CNS diseases and disordershttp://axialbiotherapeutics.com -
Benvenue Medical, Inc.
Developing devices for the treatment of back painhttp://www.benvenuemedical.com -
Biomagnetic Technologies Inc.
Biomagnetic Technologies Inc.
Instrumentation for ultra-sensitive magnetic measurement -
BioNano Genomics, Inc.
Developing technologies for analysis of large biological moleculeshttp://www.bionanogenomics.com -
Biosite Diagnostics, Inc.
Discovery, development and marketing of rapid diagnostics -
BioVascular, Inc.
Developing solutions for reducing inflammation and thrombosishttp://www.biovascularinc.com -
BiPar Sciences, Inc.
Developing and commercializing potential new classes of tumor-selective drugs -
British Biotech
British Biotech
Diversified life-sciences company developing both drugs and research products -
Cabrellis Pharmaceuticals Corporation
Development of important therapies for the treatment of cancer -
Cadence Pharmaceuticals, Inc.
Development and marketing of acute care drugs with an initial focus on anti-infectives - Cadent Medical Corporation
-
Calixa Therapeutics, Inc.
Focused on developing, acquiring and commercializing hospital-based anti-infective therapies -
Cantex Pharmaceuticals, Inc.
Developing a proprietary, modified form of heparin to treat a range of inflammatory diseaseshttp://www.cantex.com -
-
CardioDynamics International Corporation
Noninvasive digital heart monitoring devices -
CardioPolymers, Inc.
Novel therapies for diseases of cardiac conduction -
CareCentric Solutions, Inc.
Information systems for the home care industry -
Carticept Medical, Inc.
Development and sales of therapeutically related medical deviceshttp://www.carticept.com -
Cartiva, Inc.
Development of medical devices to treat knee and small joint diseasehttp://www.cartiva.net -
Celator Pharmaceuticals, Inc.
Development of proprietary fixed dose combinations of chemotherapeutic agents for cancer treatmenthttp://www.celatorpharma.com/ -
Celladon Corporation
Developing treatments for cardiovascular diseases through molecular cardiology -
Celtaxsys, Inc.
Focused on treatments for inflammatory disease via regulation of immune cell migration & activationhttp://www.celtaxsys.com -
Cerexa, Inc.
Focused on developing, acquiring and commercializing hospital-based anti-infective therapies -
ChromaCode, Inc.
Developing intelligent multiplexing for qPCR based diagnostic systemshttp://www.chromacode.com -
Ciblex Corporation
Development of drugs that impact protein trafficking for use in proliferative disorders -
Clovis Oncology, Inc.
Focused on acquiring, developing and commercializing innovative anti-cancer agentshttp://www.clovisoncology.com - CoCensys, Inc.
-
Colorescience, Inc.
Markets products which fuse the beauty of traditional makeup with the benefits and efficacy of skin care and sun protectionhttp://www.colorescience.com -
CoLucid Pharmaceuticals, Inc.
Developing innovative therapies to treat CNS disordershttp://www.colucid.com -
-
Connetics Corporation
Development and marketing of dermatology drugs -
Corridor Pharmaceuticals, Inc.
Developing therapeutics for vascular and pulmonary indications -
Corthera, Inc.
Development of Relaxin for various indications -
Cortria Corporation
Developing safe and well-tolerated medicines to fight cardiovascular disease -
Cotera, Inc.
Developing new and innovative orthopedic devices - Creative Biomolecules, Inc.
-
Cytovia, Inc.
Cytovia, Inc.
Drug screening technology using proprietary apoptosis assays -
DIANON Sytems Inc.
Provides anatomic and clinical pathology, patient information, and business solutionshttp://www.dianon.com -
Dicerna Pharmaceuticals, Inc.
Developing RNA dicer substrates to treat a variety of diseaseshttp://www.dicerna.com -
DiObex, Inc.
Development of drugs to improve the management of diabetic patientshttp://www.diobex.com -
DNX Corporation
DNX Corporation
Development of in vitro and in vivo biological modelsMerged with BioClin to form Chrysalis International Corporation, subsequently acquired by Phoenix International Life Sciences, part of MDS Pharma -
Domain AntiBacterial Acquisition Corporation
Domain AntiBacterial Acquisition Corporation
In-licensing of anti-infective drugs -
Domain Elite Holdings Ltd.
Domain Elite Holdings Ltd.
A unique collaboration designed to create businesses in China -
DRI Holdings Limited
Formed in conjuction with Rusnano to provide funding for Domain companies and establish NovaMedicahttp://dri.com.ru -
Dura Pharmaceuticals, Inc.
Specialty pharmaceutical company focused on respiratory drugs -
Durata Therapeutics, Inc.
Development of Dalbavancin, a glycopeptide anti-bacterial agenthttp://www.duratatherapeutics.com -
Eddingpharm International Holdings Limited
Marketing oncology products in Chinahttp://www.eddingpharm.com -
Embrex, Inc.
Unique delivery system for poultry vaccines and therapeuticsAcquired by Pfizer Animal Health -
-
-
Esperion Therapeutics, Inc.
Developing pharmaceutical products for the treatment of cardiovascular and metabolic diseaseshttp://www.esperion.com -
Esprit Pharma, Inc.
Acquisition, development and marketing of drugs for the urology and OB-GYN physician communities -
Eunoe, Inc.
Device to treat Alzheimer's disease -
Evofem Biosciences, Inc.
Developing a portfolio of therapeutic solutions to meet the evolving sexual and reproductive health needs of women globallyhttp://www.evofem.com -
Evoke Pharma, Inc.
Acquisition and development of proprietary products for the treatment of gastrointestinal diseaseshttp://www.evokepharma.com -
-
Five Prime Therapeutics, Inc.
Expression and screening of all secreted proteins to find relevant protein therapeuticshttp://www.fiveprime.com -
Focal, Inc.
Focal, Inc.
Biodegradable materials for the prevention of surgical adhesionsAcquired by Genzyme BioSurgery -
Fractyl Laboratories, Inc.
Developing device based treatment for chronic diseasehttp://www.fractyl.com -
Fusion Medical Technologies, Inc.
Fusion Medical Technologies, Inc.
Biomaterial for use in surgical procedures to prevent adhesions -
GelTex Pharmaceuticals, Inc.
GelTex Pharmaceuticals, Inc.
Polymer technology for drugs that stay in the GI tract and remove toxins -
Gene Sciences, Inc.
Developing a new oncology product for treatment of late-stage prostate cancerhttps://genesciencesinc.com/ -
-
GenQuest, Inc.
GenQuest, Inc.
Gene identification for diagnostic and therapeutic applications -
Gensia Pharmaceuticals Inc.
Gensia Pharmaceuticals Inc.
Development of drugs to treat cardiovascular diseases -
Genta Incorporated
Development of antisense therapeutics -
-
Geron Corporation
Discovery of mechanisms and therapeutics that impact the aging processhttp://www.geron.com -
-
-
GlycoDesign
GlycoDesign
Development of novel therapeutics for treatment of cancer, infectious diseases and inflammationAcquired by Inflazyme -
Goodwell Technologies, Inc.
IT to allow for remote doctor-patient interactionhttp://www.goodwelltech.com -
-
Helixis, Inc.
Developing a molecular diagnostic testing platform for use in diverse physical locations -
Imagine Pharmaceuticals, Inc.
Technology to facilitate delivery of drugs to the brain -
Imagyn Medical, Inc.
Imagyn Medical, Inc.
Medical devices for gynecological indicationsAcquired by UroHealth, renamed Imagyn Medical Technologies, Inc. -
Immune Control, Inc.
Developing drugs to stop undesirable proliferation of immune cells -
Immunex Corporation
Focused on products for rheumatoid arthritis, acute nonlymphocytic leukemia and pain -
Inspire Pharmaceuticals, Inc.
Drug development for ophthalmic and respiratory diseases -
-
IntraLase Corporation
Devices for laser correction of vision -
-
-
Iterum Therapeutics Plc
Developing differentiated anti-infectives aimed at combating multi-drug resistant pathogens to treat serious and life-threatening diseaseshttp://iterumtx.com -
Kalidex Pharmaceuticals, Inc.
Providing next-generation anti-infective therapies to the marketplace -
Kona Medical, Inc.
Developing methods to non-invasively inhibit or ablate nerveshttp://www.konamedical.com -
Konova, Inc.
Konova, Inc.
Anti-obesity drug development -
LaJolla Pharmaceutical Company
Development of therapeutics for antibody-related disordershttp://www.ljpc.com -
Landec Corporation
Crystallizable polymers for a variety of medical and industrial applicationshttp://www.landec.com -
Lumisys, Inc.
High-performance electro-optical systems for medical imaging -
Marinus Pharmaceuticals, Inc.
Development of therapeutics for treatment of CNS disorders and painhttp://www.marinuspharma.com -
Medico (Hong Kong) Limited
Medico (Hong Kong) Limited
Chinese affiliate of Smart Medical Systems Ltd. Developing and commercializing novel endoscopic products for the Chinese market -
-
Microgon Inc.
Microgon Inc.
Hollow-fiber membrane filters for use in research laboratories -
Microsurge
Microsurge
Improved instrumentation for minimally invasive surgeryAcquired by UroHealth, renamed Imagyn Medical Technologies, Inc. -
-
MIGENIX Inc.
Development of drugs for the prevention and treatment of infectious diseases -
Milestone Pharmaceuticals, Inc.
Developing fast-acting therapies to resolve cardiac rhythm disordershttp://www.milestonepharma.com -
-
MitoKor
Discovery and development of drugs for mitochondrial diseasesAcquired by Micrologix Biotech Inc. (now MIGENIX Inc.) -
Molecular Dynamics
Molecular Dynamics
Use of optical technology to automate laboratory processesAcquired by Amersham Pharmacia Biotech -
Molecular Staging, Inc.
Biomarker discovery utilizing novel DNA/RNA amplification technology -
Nanothera Corporation
Developing safer parenteral products for hospital use -
Neose Technologies, Inc.
Enhancement of drugs by glcyosylation -
Neuralieve, Inc.
Developing a non-invasive medical device to treat migraine headaches -
-
Northstar Neuroscience, Inc.
Electrical stimulation to treat neurological defects -
-
-
Novadigm Therapeutics, Inc.
Developing vaccines and therapeutics to prevent and treat infectious diseaseshttp://www.novadigm.net -
Novalar Pharmaceuticals, Inc.
Development of dental medications -
-
Nuon Therapeutics, Inc.
Developing medicines to treat autoimmune disease -
-
Obalon Therapeutics, Inc.
Developing an orally available intragastric balloon for the treatment of obesityhttp://www.obalon.com -
-
Ocera Therapeutics, Inc.
Development of drugs to treat gastrointestinal diseaseshttp://www.ocerainc.com -
Ocunexus Therapeutics, Inc.
Development and commercialization of proven gap junction channel modulation technologies targeting unmet clinical needs in ophthalmologyhttps://www.ocunexus.com -
-
OmniSonics Medical Technologies, Inc.
Device to remove vascular occlusionshttp://www.omnisonics.com -
OncoTherapeutics, Inc.
OncoTherapeutics, Inc.
Cancer diagnostics and therapeutics based on Kallikrein family of proteins -
Onux Medical, Inc.
Minimally invasive surgical tools -
-
Optherion, Inc.
Developing therapeutics for diseases involving the complement system, with an initial focus on AMD -
-
Oraya Therapeutics, Inc.
Developing a radiation-based treatment for wet AMD -
-
Origin Medsystems Inc.
Origin Medsystems Inc.
Instruments and devices for minimally invasive surgery -
Orqis Medical Corporation
Device to treat congestive heart failure -
Otonomy, Inc.
Developing novel drug therapies for disorders of the inner and middle earhttp://www.otonomy.com -
-
-
Pointshare Corporation
Community-based healthcare intra and extranet solutions -
ProteinSimple
Lab instrumentation enabling analysis of cell signaling activityhttp://www.proteinsimple.com -
Proxima Therapeutics, Inc.
Novel system to deliver radiation to treat cancer -
Receptor BioLogix, Inc.
Developing a new class of protein therapeutics called Intron Fusion Proteins -
Regado Biosciences, Inc.
Developing rapidly reversible anti-clotting medications -
-
-
ReVision Optics, Inc.
Developing new technologies, products and procedures aimed at the correction of presbyopiahttp://www.revisionoptics.com -
RiboGene, Inc.
RiboGene, Inc.
Therapeutics based on control of protein translation -
RightCare Solutions, Inc.
An evidence-based technology company specializing in discharge planning and readmission managementhttp://www.rightcaresolutions.com -
-
Ruxton Pharmaceuticals, Inc.
Proprietary assays to discover and develop drugs to treat ALS -
Santarus, Inc.
GI drug development using novel formulations -
Sebacia, Inc.
Developing novel technology to address a large unmet need in dermatologyhttp://www.sebacia.com -
Selective Genetics, Inc.
Site-specific gene therapies primarily for tissue repair -
-
-
Sepracor, Inc.
Separation technology applied to drug discovery -
Sequel Pharmaceuticals, Inc.
Cardiovascular drug development -
Sequent Medical, Inc.
Dedicated to the development of innovative devices to treat neurovascular disease conditionshttp://www.sequentmedical.com -
Sera Prognostics, Inc.
Developing diagnostic tests for early prediction of preterm birth and other pregnancy complicationshttp://www.seraprognostics.com -
Sievers Instruments, Inc.
Sievers Instruments, Inc.
Novel detectors for gas chromatography -
-
Small Molecule Therapeutics, Inc.
Discovery of small molecule drugs based on proprietary screening technologyAcquired by MorphoChem AG -
Smart Medical Systems Ltd.
Developing and commercializing novel products to enable better endoscopy for the gastroenterologisthttp://www.smartmedsys.com -
Somaxon Pharmaceuticals, Inc.
Development of psychiatric drugs -
Sonexa Therapeutics, Inc.
Developing therapeutics for the treatment of Alzheimer's disease -
Syndax Pharmaceuticals, Inc.
Development and commercialization of novel cancer therapieshttp://www.syndax.com -
Tandem Diabetes Care, Inc.
Developing novel devices for the treatment of diabeteshttp://www.tandemdiabetes.com -
-
Tobira Therapeutics, Inc.
Dedicated to the clinical development of antiviral productshttp://www.tobiratx.com -
Tragara Pharmaceuticals, Inc.
Development of proprietary drugs for the treatment of cancer and inflammation-related disordershttp://www.tragarapharma.com -
Trega Biosciences, Inc.
Trega Biosciences, Inc.
Combinatorial chemistry technology used to discover novel therapeuticsAcquired by LION bioscience -
-
Twelve, Inc.
An incubator focused on developing the next generation of medical device innovations -
Univax Biologics
Univax Biologics
Vaccines to stimulate the plasma donor production of immunoglobulins -
US Bioscience, Inc.
Acquisition and marketing of cancer drugs -
Valley Forge Pharmaceuticals, Inc.
Anti-myopia drug development -
Vanda Pharmaceuticals, Inc.
Analysis of genetic, genomic and clinical date to rescue "failed" drugshttp://www.vandapharma.com -
-
Vascular Therapeutics, Inc.
Vascular Therapeutics, Inc.
Biopharmaceuticals for the prevention and treatment of vascular disease -
VenPro Corporation
Intravascular valve technology -
VentiRx Pharmaceuticals, Inc.
Developing novel drugs for the treatment of cancer, infectious, respiratory and autoimmune diseases.http://www.ventirx.com -
Veracyte, Inc.
Developing a molecular-based thyroid cancer diagnostic that permits diagnoses without surgeryhttp://www.veracyte.com -
Verus Pharmaceuticals, Inc.
Development and marketing of pediatric focused therapeutics -
Viagene Inc.
Viagene Inc.
Gene manipulation technology for the discovery of anti-infective therapies -
Vista Medical Technologies, Inc.
Visualization technology to aid in surgical procedures -
-
-
WindMIL Therapeutics, Inc.
Novel cell therapy utilizing re-activated T-cells that normally lie dormant in cancer patientshttp://windmiltherapeutics.com -
X-Ceptor Therapeutics, Inc.
Drug development focused on orphan nuclear receptors -
Xagenic, Inc.
Developing a true point-of-care platform to enable on-demand, near patient molecular testinghttp://www.xagenic.com -
Xcel Pharmaceuticals, Inc.
Acquires & markets neurology products -
Zogenix, Inc.
Development and commercialization of medicines to treat CNS disorders and painhttp://www.zogenix.com -
